ESYT3 Knockout HEK293 Cell Line
Cat.No.:
EDC07620
Species:
Human
Cell Name:
HEK293
Gene:
ESYT3
Gene ID:
83850
Size:
1×10⁶cells
ESYT3 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07620 |
|---|---|
| Product Name | ESYT3 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | ESYT3 |
| NCBI Gene ID | |
| Gene Synonyms | CHR3SYT|E-Syt3|FAM62C |
| Summary |
Predicted to enable calcium ion binding activity and phospholipid binding activity. Predicted to be involved in endoplasmic reticulum-plasma membrane tethering and lipid transport. Located in cytoplasmic side of plasma membrane; endoplasmic reticulum membrane; and endoplasmic reticulum-plasma membrane contact site. [provided by Alliance of Genome Resources, Jul 2025]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying ESYT3 function, ESYT3 Knockout HEK293 Cell Line or ESYT3 overexpression HEK293 Cell Line?
The choice depends on whether you are studying ESYT3 (extended synaptotagmin 3)'s role as an ER-plasma membrane contact site protein or its functions in non-vesicular lipid transfer between organelles. The Knockout line is the standard tool for asking whether ESYT3 is required for these processes — extended synaptotagmins (ESYT1, ESYT2, ESYT3) are tethering and lipid transfer proteins at ER-PM contact sites, containing N-terminal hairpin (ER anchor), SMP (synaptotagmin-like mitochondrial-lipid-binding protein) domain for glycerophospholipid transfer, and C-terminal C2 domains (PM binding). Overexpression is useful for studying ESYT3 gain-of-function effects.
Important consideration: ESYT family members (ESYT1, ESYT2, ESYT3) share substantial functional overlap — single ESYT3 knockout may show modest phenotypes if ESYT1/2 compensate. This product complements the parallel ESYT2 Knockout and the ESYT2 & ESYT3 Double Knockout in HEK293 (both also available) for systematic ESYT family functional dissection. Rescue with wild-type or lipid-transfer-deficient ESYT3 is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• ER-PM contact site morphology: confocal imaging of ER-PM junctions and contact site frequency analysis.
• Glycerophospholipid transfer: lipid analytical assays to characterize non-vesicular phospholipid transfer at ER-PM contact sites.
• ESYT family dissection: parallel analysis with ESYT2 KO and ESYT2&ESYT3 Double KO in HEK293 (both also available) for paralog-specific characterization.
• Calcium signaling: ER-PM contact site-dependent SOCE (store-operated calcium entry) and PI(4,5)P2 replenishment.
EDITGENE recommends this model for researchers investigating ER-PM contact site biology, particularly when combined with parallel ESYT2 KO and double KO products.
Is this ESYT3 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. ESYT3 rescue experiments require attention to ER-PM contact site architecture:
• Construct design: use a codon-modified ESYT3 sequence with a small C-terminal tag (FLAG, HA). ESYT3 has N-terminal hairpin (ER membrane anchor), SMP domain (lipid transfer), and three C2 domains (PM binding) — preserve all elements.
• SMP-domain-mutant rescue: SMP domain mutations disrupt lipid transfer activity without affecting tethering.
• C2-domain-mutant rescue: C2 domain mutations disrupt PM PI(4,5)P2 binding and ER-PM tethering.
• Functional readout: rescue should restore ER-PM contact site formation and glycerophospholipid transfer.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download